340B Misinformation Makes Up Small Part of 340B Conversations Online, But Garners Outsized Attention, Analysis Finds

Storyful Rx analyzed more than 6,000 social media posts and articles mentioning the 340B program between Aug. 11, 2024 and Feb. 11, 2025.
…
Read More »

Drug Industry-Funded Study Finds 340B Contract Pharmacy Bills Costly to Employer Health Plans and States; Critics Slam Its Methodology and Funding Source

IQVIA examined how state 340B contract pharmacy access bills could affect state and local governments in a Feb. 4 white paper funded by the National Pharmaceutical Council.
…
Read More »

Study Finds 340B Providers Prescribe More Often Without Increasing Survival Rate of Breast Cancer; Hospital Advocate Challenges Conclusion

The Feb. 3 study compared 340B versus non-340B provider prescribing patterns for breast cancer patients.
…
Read More »

Panelists at Healthcare Purchaser Conference Link 340B to Higher Employer Healthcare Costs, Hospital Consolidation

Bret Jackson, president and CEO of the Michigan Economic Alliance, moderated a Nov. 19 panel with U.S. Rep. Victoria Spartz (R-Ind.), Thomas Johnson, executive director of ASAP 340B, and Ge Bai, Ph.D., professor of accounting and health policy at Johns Hopkins University.
…
Read More »

Drug Industry-funded Think Tank Raises Questions About 340B Hospitals’ Charity Care

The Pioneer Institute for Public Policy Research compared 29 financially strong 340B hospitals/health systems’ performance on charity care in an Aug. 19 brief.
…
Read More »

Site Footer Live